Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
-5.88% $1.200
America/New_York / 21 mar 2023 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 86.61 mill |
EPS: | -1.330 |
P/E: | -0.902 |
Earnings Date: | Aug 07, 2023 |
SharesOutstanding: | 72.17 mill |
Avg Daily Volume: | 0.815 mill |
RATING 2023-05-22 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.902 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.15x |
Company: PE -0.902 | industry: PE 5.88 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.047 - 1.353 ( +/- 12.75%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-02 | Kadia Siddhartha | Sell | 645 294 | Common Stock |
2023-10-02 | Chiminski John R | Sell | 71 225 | Common Stock |
2023-10-02 | Chiminski John R | Sell | 41 240 | Common Stock |
2023-10-02 | Silvester Peter | Sell | 140 000 | Common Stock |
2023-10-02 | Silvester Peter | Sell | 64 596 | Common Stock |
INSIDER POWER |
---|
-73.01 |
Last 96 transactions |
Buy: 4 289 476 | Sell: 12 868 379 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.200 (-5.88% ) |
Volume | 2.29 mill |
Avg. Vol. | 0.815 mill |
% of Avg. Vol | 280.62 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.